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Abstract
Background:  Zebrafish are increasingly used to study the influences of gene mutation and
manipulation on cardiac development, structure and function. In this study, a video edge detection
system was used to characterise, continuously, cardiac ventricle function in 2–5 days old zebrafish
embryos embedded in 0.6% agar and examined under light microscopy at room temperature
(22°C). Using video edge detection software (IonOptix Inc), the motion of a small region of the
cardiac ventricle wall was converted to a continuous chart trace allowing analysis of wall motion
amplitude (WMA) and myocardial wall velocity during systole (MWVs) and diastole (MWVd).
Results: Cardiac wall motion characteristics changed progressively from day 2 to 5 (WMA, 2-days,
17.6 ± 4.4 µm vs 5-days, 24.6 ± 4.7 µm, p < 0.01). MWVd was more rapid than MWVs at all
developmental time points. Embryonic hearts were also assessed after increasing concentrations of
norepenephrine (NE) and the anaesthetic agent MS222 (tricaine) were added to the bathing water.
In response to NE, WMA increased significantly more in 4 day embryos compared with 2 day
embryos (change in WMA,13.6 ± 8.2 µm vs 4.0 ± 8.8 µm, p = 0.01, respectively) while the decrease
in WMA in response to MS222 was similar in both 2 and 4-day embryos. Heart rate, MWVs and
MWVd were significantly higher at 28°C compared with 22°C. No differences in cardiac function
were observed between AB and Golden strains.
Conclusion:  Video edge detection appears sufficiently sensitive to detect subtle changes in
diastolic and systolic cardiac function during development and changes resulting from
pharmacological and environmental interventions. Such measurements could be valuable in
assessment of altered cardiac function after genetic manipulation.
Background
In the short period that the zebrafish (Danio rerio) has
been utilised for biomedical studies it has emerged as a
powerful genetic tool and an ideal model system for both
organogenesis and as a vertebrate model for human dis-
ease [1]. The embryonic zebrafish heart is the first organ
to develop, and shows similarity to the embryonic human
heart, specific comparison has been drawn to show devel-
opmental parity between the 24 hours post fertilisation
(hpf) zebrafish heart and the human heart at three weeks
[2,3]. One clear advantage of utilising the zebrafish, as a
model organism, is that normal cardiac function in
embryonic zebrafish is not required for several days, suffi-
cient oxygen is obtained by diffusion [4]. Fish, unlike
rodent models, are not dependent on a cardiovascular sys-
tem for survival during embryogenesis. Cardiac activity is
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not coupled with metabolic demand [5] and hence defects
in cardiac development or function are less likely to result
in early mortality. Furthermore, the zebrafish embryo is
virtually transparent which permits imaging of internal
organs, especially the heart, using standard light micros-
copy. For these reasons, the zebrafish is an ideal model
system in which to examine developmental biology and
organogenesis.
The zebrafish heart is essentially two chambered with
valves dividing the atrium and ventricle and a second
valve separating the ventricle from the outflow tract or
bulbous arteriosum [6]. Prior to 22 hpf the lateral cardiac
primordia join to form a definitive heart tube which
begins to contract in a coordinated, rhythmic fashion and
by 24 hpf contributes to circulation by peristaltic waves.
At 36 hpf morphological differentiation from the heart
tube to chambers is observed and by 72 hpf the circulatory
system is more mature with the heart having looped to
form a dorsally positioned atrium [7]. All major organs
are present by this stage. By 5-days post fertilisation (dpf)
the embryonic heart is essentially that of an adult teleost
configuration [7,8] with a functional cardiovascular sys-
tem conforming to a vertebrate developmental plan [9].
The zebrafish embryo measures approximately 3.5 mm in
length at 3 dpf. This small size presents a technical chal-
lenge to assessment of the functional characteristics of the
heart. Unsurprisingly therefore, many previous studies
have focused predominantly on counts of heart rate
observed directly by microscopy or combined with video
image capture [10-12]. These studies have limitations in
that simple measures of heart rate do not provide infor-
mation on cardiac contractility. Other studies have
reported estimates of cardiac output and ejection fraction
using single systolic and diastolic video frames from light
microscopy to derive cardiac output and ejection fraction
[13]. Such estimates are limited in that they are derived
from 2-dimensional images using geometric assumptions
of ventricular shape and they reflect systolic function
only; there are no reports of measures of diastolic function
in the zebrafish. More recently reported techniques using
rotational imaging [14] and confocal microscopy [15]
provide detailed three dimensional imaging of the
zebrafish embryonic heart but this is not widely available
and is relatively expensive and time consuming to per-
form. Furthermore, other than counts of heart rate, the
effects of pharmacological interventions on cardiac systo-
lic and diastolic function have not been widely studied.
The aim of this study was to assess and implement a tech-
nique which would allow the continuous assessment of
heart rate, ventricular wall motion amplitude and wall
motion velocity in systole and diastole. This technique
potentially allows the accurate assessment of both the
extent of response and the time course of responses to var-
ious physiological and pharmacological interventions
and could be adapted to high throughput screening.
Results
Cardiac wall motion changes during development (days 2 
to 5)
Table 1 summarises the baseline characteristics of heart
rate, myocardial wall velocity in systole (MWVs), myocar-
dial wall velocity in diastole (MWVd) and wall motion
amplitude (WMA) for zebrafish embryos ranging from 2
to 5 dpf. The 2-day embryos had significantly lower heart
rates, amplitude of wall motion and significantly lower
MWVs. MWVd was also lower but this did not reach statis-
tical significance. Of note, and not previously reported,
the rate of ventricular relaxation, as assessed by MWVd, is
significantly faster than ventricular contraction (MWVs) at
all stages of development examined in this study.
Effects of norepenephrine
Norepenephrine significantly increased heart rate, myo-
cardial wall velocity in systole, myocardial wall velocity in
diastole and wall motion amplitude in 2 and 4 day
embryos (Figure 1). The observed changes in these param-
eters were less marked in 2 day compared with 4 day
embryos (Table 2). In 2 dpf embryos, NE produced a
mean 20% increase in MWVs and a mean 15% increase in
MWVd. However, at 4 dpf NE produced a mean 75%
increase in MWVs and a mean 90% increase in MWVd.
Effects of MS222 (Tricaine)
Administration of increasing concentrations of MS222 to
the bathing water resulted in progressive reduction in
heart rate, wall motion amplitude and myocardial wall
velocities in systole and diastole in both 2 day and 4 day
embryos (Figure 2). In 2 day embryos, wall motion ampli-
tude, myocardial wall velocities in systole and diastole fell
Table 1: comparison of baseline heart rat, wall motion amplitude (WMA), myocardial wall velocity in systole (MWVs) and myocardial 
wall velocity in diastole (MWVd) at 22°C in Golden zebrafish embryos 2 to 5-days post-fertilisation (Values are mean ± (SD))
2 days (n = 6) 3 days (n = 8) 4 days (n = 7) 5 days (n = 6) ANOVA
Heart rate (bpm) 141 ± 14.2 147.2 ± 20.9 165.90 ± 16.8 171.5 ± 12.9 <0.001
MWVs (µm/s) 195.4 ± 54.3 207.6 ± 61.6 264.6 ± 75.7 275.6 ± 154.6 0.03
WMA (µm) 17.6 ± 4.4 18.2 ± 4.5 26.7 ± 7.4 24.6 ± 4.7 0.01
MWVd (µm/s) 262.2 ± 101.9 268.9 ± 108.2 402.8 ± 133.7 345.8 ± 95.0 0.09BMC Biotechnology 2008, 8:21 http://www.biomedcentral.com/1472-6750/8/21
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by approximately 30% before any significant reduction in
heart rate was observed. This occurred over a concentra-
tion range of MS222 normally used in our laboratory for
anaesthesia (70–100 mg/litre). In 4 day embryos, there
was a slight rise in the mean myocardial wall velocity in
diastole at low doses of MS-222 accompanied by a small
rise in heart rate (Figure 2). At higher doses the heart rate
fell in conjunction with other wall motion parameters.
Effects of temperature on zebrafish cardiac function
Heart rate was significantly higher at 28°C compared with
22°C (Table 3). Wall motion amplitude did not change
significantly at higher temperature but there was a signifi-
cant increase in myocardial wall velocity in systole and a
borderline significant increase in myocardial wall velocity
in diastole.
Effects of zebrafish strain (Golden vs. AB)
Comparing AB and Golden strains at 3 days and 5 days,
there were no significant differences observed in the any
of the wall motion characteristics at these developmental
time points (data not shown).
Discussion
This study has applied a video-edge detection technique
previously validated in assessing motion in mammalian
single cardiac myocytes [16]. The technique provides con-
tinuous measurement of a number of cardiac parameters
which reflect different aspects of cardiac function: heart
rate, amplitude of myocardial wall movement, 
Peak responses to norepenephrine in 2-day (n = 6) and 4-day (n = 6) zebrafish embryonic hearts (values are mean ± SD) Figure 1
Peak responses to norepenephrine in 2-day (n = 6) and 4-day (n = 6) zebrafish embryonic hearts (values are mean ± SD).
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Table 2: peak change from baseline in heart rate, wall motion 
amplitude (WMA), myocardial wall velocity in systole (MWVs) 
and myocardial wall velocity in diastole (MWVd) in response to 
norepenephrine: 2-day vs 4-day embryos (Golden strain)
2-days (n = 5) 4-day (n = 7) P*
Heart rate (bpm) +11.6 ± 7.2 +19.9 ± 7.3 0.07
WMA (µm) +4.0 ± 8.8 +13.6 ± 8.2 0.07
MWVs (µm/s) +41.7 ± 88.8 +184.9 ± 126.1 0.05
MWVd (µm/s) +42.6 ± 75.6 +364.7 ± 139.9 <0.001
*comparison between 2 and 4 day embryosBMC Biotechnology 2008, 8:21 http://www.biomedcentral.com/1472-6750/8/21
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myocardial wall velocity during systole and myocardial
wall velocity during diastole. Assessing these parameters
during the first 5 days of development has revealed a pro-
gressive increase in heart rate and progressive improve-
ment of wall motion characteristics at 24 hour intervals.
Furthermore, we have demonstrated clear changes in
myocardial wall velocities in systole and diastole in
response to drugs administered into the bathing water
and changes resulting from alteration in bathing water
temperature. The findings therefore not only suggest that
this technique is feasible but that it has the capacity and
sensitivity to detect both large and small differences in car-
diac function which could result from genetic or environ-
mental manipulation.
Table 3: effects of temperature on baseline heart rate, wall 
motion amplitude (WMA), myocardial wall velocity in systole 
(MWVs) and myocardial wall velocity in diastole (MWVd) in 3 
day Golden embryos (n = 6) at 22°C and 28°C (values are mean ± 
SD).
Temperature
22°C 28°C P
Heart rate (bpm) 136.2 ± 8.3 276.2 ± 22.0 <0.001
MWVd (µm/s) 265.2 ± 66.1 364.9 ± 117.2 0.07
MWVs (µm/s) 172.6 ± 40.3 316.3 ± 89.5 0.02
WMA (µm) 17.2 ± 3.6 15.6 ± 3.5 0.46
Effects of increasing concentrations (M, moles)   of anaesthetic agent MS222 on cardiac function in 2 and 4-day embryo hearts  (shaded area represents typical range of concentrations of MS222 used for fish anaesthesia). Figure 2
Effects of increasing concentrations (M, moles)   of anaesthetic agent MS222 on cardiac function in 2 and 4-day embryo hearts 
(shaded area represents typical range of concentrations of MS222 used for fish anaesthesia).
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The technique is also useful in determining responses to
drugs that are known to influence cardiac function in fish.
Drugs such as norepenephrine appear to be readily
absorbed through the gills even with the embryo embed-
ded in a weak agar solution. Other workers have reported
similar responses to cardio-active drugs when introduced
into the bathing water [17-19]. This pharmacological
approach provides the potential for experiments examin-
ing the responsiveness of zebrafish myocardium to car-
dio-active drugs following genetic manipulations which
potentially induce phenotypes analogous to human cardi-
omyopathy or heart failure [20,21]. In this way, altered
responsiveness to such drugs could be useful in detecting
and further defining similarities in phenotype to human
disease.
The findings of this study also provide insights into devel-
opmental time points of the adrenergic system in the
zebrafish heart. While norepenephrine had a significant
effect on 4-day zebrafish embryo hearts this was much less
obvious in 2-day embryos. The difference in response to
norepenephrine was most marked for relaxation velocity
which is known to be strongly influenced by adrenorecep-
tor mechanisms in mammalian tissue. This is consistent
with previously published work in zebrafish showing
response of heart rate to isoproterenol [19] at various
developmental time points and work showing an increase
in cardiac out put in 3 and 4-day zebrafish embryos
injected with norepenephrine [17]. The ability to assess
cardiac chamber wall motion directly provides more spe-
cific information on the response of the heart to drugs
compared with techniques focusing on heart rate alone.
Such studies have reported bradycardia in response to
drugs known to prolong repolarisation [18] but there are
also reports of bradycardia in response to drugs not
known to act directly on cardiac conducting mechanisms,
such as warfarin and atorvastatin [12]. This highlights the
need for characterisation of drug responses in the
zebrafish heart using techniques that assess not only heart
rate but also chamber specific wall motion.
In contrast to norepenephrine, the anaesthetic agent
MS222 was found to depress cardiac function in a dose
dependent fashion in 2 and 4-day embryos. This suggests
that the mechanism of action of this drug on the heart is
established as early as 48 hours after fertilisation. Previous
studies have described a decrease in heart rate at higher
concentrations of MS222 and a slight increase at lower
concentrations [22]. One previous study suggested a
reduction in stroke volume and cardiac output measured
indirectly using aortic blood flow [23]. Previous studies
have described greater sensitivity to MS222, in terms of
lethality and deep anaesthesia, at younger gestation [24].
Our study goes further and suggests that significant reduc-
tions in cardiac wall motion indices occur in 2-day
embryos even before any change in heart rate is observed.
This important finding raises the possibility that there is
significant depression of cardiac contractility at concentra-
tions of MS222 widely used for fish anaesthesia in
younger embryos. In the study reported here, all assess-
ment of cardiac wall motion comparing 2 – 5 day
embryos was conducted without anaesthesia with the fish
immobilised in agar.
The effect of temperature on zebrafish heart rate has been
examined previously in normal zebrafish [25] and in the
zebrafish breakdance mutant [11]. Heart rate appears to
show a steep positive association with temperature with
rates of up to 260 beats per minute reported at 31°C. In
this study we have shown a similar steep relationship
between temperature and heart rate and we have also
demonstrated, for the first time, significant increases in
the velocity of the myocardial wall during contraction and
a trend for enhanced velocity during relaxation at higher
temperatures. This confirms a close coupling between
myocardial metabolism and temperature and supports
the need for careful temperature control during experi-
ments assessing cardiac function in poikilothermic fish.
There were no differences observed between AB and
Golden strains of zebrafish comparing 3 day and 5-day
embryos. AB strain heart rates found in this study are sim-
ilar to those found by other workers, however, a wide
range for heart rates has been reported ranging from 140–
190 beats per minute at 3-days to 135–230 beats per
minute at 5-days [22,26]. Different heart rates have been
reported in Albino and AB strains [17,19] but this is the
first report comparing different strains using qualitative
assessment of heart rate and cardiac wall motion.
Screening large numbers of zebrafish embryos is a strategy
widely used to identify phenotypic features suggestive of
an underlying genetic defect [1,10,27]. This video edge
detection technique could be applied to examine more
sensitively for cardiac wall motion abnormalities in such
screens. However, the technique does require a degree of
operator skill and it is likely that the number of fish that
could be assessed per day would be approximately 30–40.
It is possible that the technique could be combined with
more automated microscopic systems, using wells with
individual fish to provide more rapid assessment of ven-
tricular wall movements. While this would be valuable,
the technique also lends itself to the evaluation of quali-
tative differences in cardiac function at specified develop-
mental time points and could be used in knock down
experiments [28] of genes known to affect cardiac per-
formance.BMC Biotechnology 2008, 8:21 http://www.biomedcentral.com/1472-6750/8/21
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Conclusion
This study has outlined a novel method for assessing car-
diac wall motion in zebrafish embryos from 2-days to 5-
days post-fertilisation. The technique extends our ability
to assess cardiac function from, simple measures of heart
rate and snap-shot assessments of changes in ventricular
area using single frame images, to continuous assessment
of wall motion. The technique appears sensitive to phar-
macological and physiological interventions and provides
a relatively inexpensive method of characterising subtle
and cycle-specific changes in cardiac function resulting
from genetic and pharmacological manipulation.
Methods
Husbandry and maintenance
A zebrafish (Danio rerio) Golden (B1) strain was used
throughout this study except in one experiment where car-
diac motion characteristics in this Golden strain were
compared with the AB strain. Fish were maintained at
28.5°C under standard conditions [29,30] and unless
stated the experimental protocols were conducted at room
temperature (22°C).
Embryos were collected from random Golden matings
and when correctly aged were anaesthetised (20 µM buff-
ered MS-222, Sigma) and if required embryos were
mechanically removed from their chorion. Embryos were
then embedded in 2 ml 0.6% SeaKem LE agarose (Cam-
brex) and orientated carefully in a lateral position to opti-
mise visualisation of the heart. Following agar-
embedding, fish were allowed to recover in fresh system-
water (3 ml) with no anaesthetic for a minimum of 30
mins, this in turn was replenished before the commence-
ment of any experiment. Agar embedding is not consid-
ered to have detrimental effects on zebrafish embryo
physiology [22].
Video edge-detection system
SoftEdge™ (IonOptix Corporation) measures real-time
length via contrast analysis of digitized image data. A
frame-grabber card mounted in the acquisition computer
continuously digitizes the output of the video camera and
displays it on a monitor. The video camera was mounted
on a light microscope (Axioskop II MOT compound
microscope) with a ×40 water dipper objective, setup for
maximum differential interference contrast.
The user selects video lines on the edge of the heart corre-
sponding to the ventricular wall using a cursor (Figure 3).
Edge detection is based on either image intensity or the
derivative of image intensity. Edges are detected from
"outside in" and image contrast is enhanced using the
video gain and offset controls of the frame grabber PC
card. Optimal edge contrast is achieved by adjusting the
settings on the microscope and the camera. The user spec-
ifies a threshold value and a crossing condition. The com-
2-day zebrafish embryo ventricle in systole and diastole (panel A) Figure 3
2-day zebrafish embryo ventricle in systole and diastole (panel A). Inner ventricle wall is tracked by a cursor (panel B, left ver-
tical line) and the movement displayed a continuous trace (panel B, contraction is upwards).
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puter analyses each video image (see typical image in
Figure 3, panel A) and treats the crossing of the threshold
value as the edge location. This signal is displayed as a
continuous trace (Figure 3, panel B). The sampling fre-
quency of the camera was set at 120 Hz to allow optimal
temporal resolution. The signal was calibrated using a
standard millimetre graticule and values are expressed as
micrometers (wall motion amplitude) or micrometers per
second for myocardial wall velocity in systole (MWVs)
and diastole (MWVd).
Baseline assessment of cardiac wall motion during early 
development
Baseline measurements of ventricular wall motion were
observed in zebrafish embryos ranging in age from 2 to 5
dpf at 22°C. The wall tracking cursor was placed in a posi-
tion to provide an optimal trace of wall motion and
allowed to stabilise over a period of 10–20 minutes.
When a stable trace with good myocardial wall tracking
could not be obtained then this fish was discarded and the
next assessed. Successful and consistent assessment of
myocardial wall tracking was obtained in 80% or more
embryos. In 2 and 3 day embryos wall motion was
assessed in the outer wall at the mid-point of the ventricle
close to the pericardium where a consistent and stable
trace was readily obtained. In 4 and 5 day embryos, after
the heart had undergone full looping, the most stable and
consistent site to obtain a trace of the cardiac wall motion
was on the outer wall close to the atrium. Repeated sepa-
rate measurements of wall motion and velocity over a
period of 15 minutes indicated no more than a 5% varia-
tion in each of the measured parameters.
To assess the effects of agar-embedding on cardiac func-
tion, heart rate and wall motion were assessed in agar-
embedded and non-embedded 2 day embryos at baseline
and after the addition of 100 mg/ml of MS222. Embed-
ding in agar had no significant effect on the rate of onset
of MS222-induced cardiac depression with maximum
effect seen 10–15 minutes after MS222 was added to the
bathing water (data not shown).
Pharmacological interventions
Heart rate, amplitude of ventricular wall movement, wall
motion velocity in diastole and systole were observed at
baseline and after increasing concentrations of norepene-
phrine and MS222 (Sigma chemicals) were added to the
bathing water. These drugs were chosen to assess whether
the technique was sensitive to both increases and
decreases in cardiac performance resulting from pharma-
cological intervention.
In 2 day and 4 day embryos, norepenephrine was added
to a standard volume of bathing water using a micropi-
pette to give known final concentrations ranging from 10-
9 M to 10-3 M. Cardiac wall motion and heart rate were
assessed continuously throughout this period using the
video edge detection system. 10 representative cardiac
cycles were analysed 10 minutes after each concentration
of the drug was administered. This time period was cho-
sen after pilot experiments were performed assessing the
time-lag between adding the drug to the bathing water
and the onset of a measurable effect on cardiac contrac-
tion and relaxation. At the end of this period the bathing
water was refreshed 2–3 times and a new baseline estab-
lished. A similar protocol was repeated using MS222 (10-
6 M to 10-3 M) while continuously monitoring heart rate
and ventricular wall motion.
Effects of temperature on wall motion and heart rate
3-day embryos (Golden B1 strain) were embedded in agar
in a dish placed on an electronically controlled heated
microscope stage (Bioptech, Delta T open dish system).
Heart rate and cardiac wall motion were assessed at a
baseline temperature of 22°C. The stage was then progres-
sively heated to 28°C and then maintained at this temper-
ature for a further 1 hour. Heart rate and cardiac wall
motion were reassessed.
Comparison of baseline heart rate and cardiac wall motion 
in Golden and AB strains
3 day and 5 day zebrafish embryos derived from Golden
and AB strains were embedded in agar and their heart
rates and cardiac wall motion assessed at 22°C. No phar-
macological or temperature interventions were performed
on these fish.
Statistical analysis
Values represent an average of 10 cardiac cycles for each
set of conditions in individual zebrafish embryo hearts.
Data are presented as means ± standard deviation (SD). A
2-way repeated measures ANOVA was used to compare
means within and between groups. Where applicable,
Tukey's multiple comparison procedure was performed to
assess for specific pair-wise comparisons post hoc. Signif-
icance was accepted at the 5% level (p = 0.05).
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